文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

天然产物在胃食管反流病管理中的应用:作用机制、疗效及未来方向

Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions.

作者信息

Komolafe Kayode, Komolafe Titilope Ruth, Crown Olamide Olajusi, Ajiboye Basiru, Noubissi Felicite, Ogungbe Ifedayo Victor, Graham Barbara

机构信息

Environmental Science PhD Program, Jackson State University, Jackson, MS 39217, USA.

Department of Biology, Jackson State University, Jackson, MS 39217, USA.

出版信息

Nutrients. 2025 Mar 19;17(6):1069. doi: 10.3390/nu17061069.


DOI:10.3390/nu17061069
PMID:40292509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944625/
Abstract

Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder that is defined by the reflux of gastric contents into the esophagus, and it results in symptoms such as esophageal inflammation, regurgitation, and indigestion. Although proton pump inhibitors (PPIs) and histamine-2 receptor antagonists are frequently employed to treat GERD, their prolonged administration is associated with adverse effects, necessitating the development of alternative therapeutic strategies. Natural products are now recognized as promising candidates for the management of GERD due to their bioactive compounds, which possess antioxidant, anti-inflammatory, and mucosal-protective properties. The potential of natural products in the treatment of GERD is comprehensively examined in this review, with a focus on their mechanisms of action, which include acid suppression, esophageal mucosal regeneration, anti-inflammatory activity, and gut microbiota modulation. Also, the efficacy and safety of key natural products, including flavonoids, polyphenols, plant-derived oils, herbal extracts, probiotics, and dietary components, in preclinical and clinical studies, are assessed. Additionally, this review addresses the barriers confronting the translation of natural therapies into clinical practice, such as regulatory obstacles, variability in bioavailability, and the need for dosage standardization. The integration of natural products into the management of GERD has the potential to enhance conventional therapies, providing a more comprehensive and secure approach for patients.

摘要

胃食管反流病(GERD)是一种常见的胃肠道疾病,其定义为胃内容物反流至食管,并导致诸如食管炎症、反流和消化不良等症状。尽管质子泵抑制剂(PPIs)和组胺-2受体拮抗剂常用于治疗GERD,但其长期使用会带来不良反应,因此需要开发替代治疗策略。由于天然产物具有生物活性化合物,具备抗氧化、抗炎和粘膜保护特性,现在它们被认为是治疗GERD的有前景的候选物。本综述全面研究了天然产物在治疗GERD方面的潜力,重点关注其作用机制,包括抑酸、食管粘膜再生、抗炎活性和肠道微生物群调节。此外,还评估了包括黄酮类化合物、多酚、植物来源的油、草药提取物、益生菌和膳食成分在内的关键天然产物在临床前和临床研究中的疗效和安全性。此外,本综述还探讨了天然疗法转化为临床实践所面临的障碍,如监管障碍、生物利用度的可变性以及剂量标准化的需求。将天然产物纳入GERD的管理有可能增强传统疗法,为患者提供更全面、安全的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11944625/dcea44d1375c/nutrients-17-01069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11944625/dcea44d1375c/nutrients-17-01069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c583/11944625/dcea44d1375c/nutrients-17-01069-g001.jpg

相似文献

[1]
Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions.

Nutrients. 2025-3-19

[2]
Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.

Genomics Proteomics Bioinformatics. 2019-4-25

[3]
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.

Clin Gastroenterol Hepatol. 2022-5

[4]
Medicinal Plants for Management of Gastroesophageal Reflux Disease: A Review of Animal and Human Studies.

J Altern Complement Med. 2017-2

[5]
Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.

Expert Opin Pharmacother. 2010-6

[6]
Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.

J Pediatr (Rio J). 2014

[7]
Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends.

Intern Med. 2024-1-1

[8]
Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid.

Ann N Y Acad Sci. 2021-2

[9]
Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.

Cochrane Database Syst Rev. 2025-3-11

[10]
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024.

Expert Opin Pharmacother. 2024-10

引用本文的文献

[1]
The association between GERD symptoms severity and psychosocial health in palestine: a cross-sectional study.

BMC Res Notes. 2025-8-17

本文引用的文献

[1]
Efficacy and Safety of GutGard® in Managing Gastroesophageal Reflux-Related Symptoms: A Phase III, Single-Centre, Double-Blind, Randomized Placebo-Controlled Trial.

Complement Med Res. 2025

[2]
Gut microbiota, inflammatory cytokines and gastro-esophageal reflux disease: A Mendelian randomization analysis.

Medicine (Baltimore). 2025-1-31

[3]
Dietary limonene promotes gastrointestinal barrier function via upregulating tight/adherens junction proteins through cannabinoid receptor type-1 antagonistic mechanism and alters cellular metabolism in intestinal epithelial cells.

Biofactors. 2025

[4]
-An Extensive Review Focused on Recent Studies.

Foods. 2024-7-8

[5]
Investigating the causal relationship of gut microbiota with GERD and BE: a bidirectional mendelian randomization.

BMC Genomics. 2024-5-14

[6]
Evaluation of effects of curcumin on acute esophagitis in the corrosive esophagitis model in rats.

Naunyn Schmiedebergs Arch Pharmacol. 2024-9

[7]
Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study.

Front Immunol. 2024

[8]
Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.

JCI Insight. 2024-2-8

[9]
The Effect of STW5 (Iberogast) on Reflux Symptoms in Patients With Concurrent Dyspeptic Symptoms: A Double-blind Randomized Placebo-controlled Crossover Trial.

J Neurogastroenterol Motil. 2024-1-30

[10]
Management advice for patients with reflux-like symptoms: an evidence-based consensus.

Eur J Gastroenterol Hepatol. 2024-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索